Schonfeld Strategic Advisors LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $141,836 - $249,058	1,706 New	1,706 $249,000
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $468,731 - $697,856	-4,700 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$98.85 - $138.91 $128,504 - $180,583	-1,300 Reduced 21.67%	4,700 $653,000
Q2 2021 Nov 16, 2021	SELL	$65.78 - $105.02 $394,680 - $630,120	-6,000 Reduced 50.0%	6,000 $582,000
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $789,360 - $1.26 Million	12,000 New	12,000 $1.17 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $880,071 - $1.33 Million	-13,525 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $798,516 - $1.05 Million	13,525 New	13,525 $879,000
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $312,541 - $650,871	-11,361 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $3.48 Million - $4.91 Million	-85,139 Reduced 88.23%	11,361 $619,000
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $3.4 Million - $4.5 Million	90,900 Added 1623.21%	96,500 $4.03 Million
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $198,950 - $335,050	-5,000 Reduced 47.17%	5,600 $245,000
Q1 2019 May 15, 2019	SELL	$34.52 - $53.29 $6.28 Million - $9.7 Million	-182,000 Reduced 94.5%	10,600 $546,000
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $2.86 Million - $4.13 Million	96,300 Added 100.0%	192,600 $7.12 Million
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $3.16 Million - $4.14 Million	96,300 New	96,300 $3.62 Million
Q2 2018 Aug 14, 2018	SELL	$23.62 - $42.29 $2.79 Million - $4.99 Million	-117,919 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $2.17 Million - $3.34 Million	96,525 Added 451.18%	117,919 $3.04 Million
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $437,293 - $760,770	21,394	21,394 $577,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account